Eris Lifesciences Share Price

ABOUT Eris Lifesciences

• Industry Biotechnology & Drugs
• ISIN INE406M01024
• BSE Code 540596
• NSE Code ERIS

Eris Lifesciences Limited is an India-based pharmaceutical company. The Company is engaged in the manufacture and marketing of pharmaceutical products. The Company has a presence in major therapies like oral anti-diabetes, insulins, cardiovascular, vitamins/minerals and dermatology. Its flagship therapies include oral anti-diabetes, cardiovascular disease (CVD), and vitamins, minerals and nutrients (VMN). Its emerging therapies consist of dermatology, insulins, women’s health, central nervous system (CNS), oncology, and nephrology. Its portfolio of brands includes Glimisave, Eritel, LNBloc, Olmin, Crevast, Atorsave, Gluxit, Renerve, Zomelis, Cosvate, Tayo, Cyblex, Remylin, Tendia, Rabonik, Ginkocer, Psorid, Raricap, Serlift, and Onabet, among others. Its patient care initiatives (PCI) platform provides various healthcare solutions to its patients. The Company has a manufacturing plant located in Guwahati, Assam.

MANAGEMENT

• Amit Bakshi Executive Chairman of the Board, Managing Director
• Sachin Shah Chief Financial Officer
• Krishnakumar Vaidyanathan Chief Operating Officer, Executive Director
• Milind Talegaonkar Compliance Officer, Company Secretary
• Inderjeet Negi Executive Director
• Kaushal Shah Executive Director